4.92
-0.0941(-1.88%)
Currency In USD
| Previous Close | 5.01 |
| Open | 5.1 |
| Day High | 5.63 |
| Day Low | 4.8 |
| 52-Week High | 15.15 |
| 52-Week Low | 3.03 |
| Volume | 16,119 |
| Average Volume | 98,584 |
| Market Cap | 6.54M |
| PE | -1.52 |
| EPS | -3.24 |
| Moving Average 50 Days | 4.38 |
| Moving Average 200 Days | 4.05 |
| Change | -0.09 |
If you invested $1000 in Titan Pharmaceuticals, Inc. (TTNP) 10 years ago, it would be worth $0.32 as of October 20, 2025 at a share price of $4.916. Whereas If you bought $1000 worth of Titan Pharmaceuticals, Inc. (TTNP) shares 5 years ago, it would be worth $68.28 as of October 20, 2025 at a share price of $4.916.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
GlobeNewswire Inc.
Jun 27, 2025 8:05 PM GMT
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
GlobeNewswire Inc.
Jun 03, 2025 12:45 PM GMT
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“SEC”) of a registration state
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
GlobeNewswire Inc.
Apr 11, 2025 8:15 PM GMT
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C